Abstract | OBJECTIVE: To investigate the prospect for clinical use of novel retinoids YS 904012 and R 9158 in combination with IFN-gamma in inducing differentiation of acute monocytic leukemia. METHODS: The effects of novel retinoids with IFN-gamma on the differentiation and clonal proliferation of fresh leukemia cell from 6 monocytic leukemia patients were studied in vitro. Cell morphological examination, nitro tetrazolium blue reduction test and DCE, expression of CD14 and CD68 and CFU-L were used in the study. RESULTS: The primary leukemia cell, cultured with the combination of YS 904012 and IFN-gamma, became more mature in morphology. The NBT reduction rate and DCE were increased from 23.4% and 25.0% to 61.5% and 52.0%, respectively. The expression of CD14 and CD68 was increased. The growth of the leukemic colony in semi-solid culture was markedly inhibited. The activity of YS 904012 combined with IFN-gamma in inhibiting proliferation and inducing differentiation of monoblast was greater than that of R9158 or all-trans retinoic acid in combination with IFN-gamma (P < 0.01). CONCLUSION:
|
Authors | H Chen, G Sun, R Han |
Journal | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
(Zhonghua Xue Ye Xue Za Zhi)
Vol. 20
Issue 1
Pg. 10-3
(Jan 1999)
ISSN: 0253-2727 [Print] China |
PMID | 11498835
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Retinoids
- Interferon-gamma
|
Topics |
- Adult
- Aged
- Cell Division
(drug effects)
- Cell Transformation, Neoplastic
(drug effects)
- Drug Synergism
- Female
- Humans
- Interferon-gamma
(pharmacology)
- Leukemia, Monocytic, Acute
(pathology)
- Male
- Middle Aged
- Neoplastic Stem Cells
(pathology)
- Retinoids
(pharmacology)
- Tumor Cells, Cultured
|